Related Experiment Video
Updated: May 9, 2026
07:51
Refined Murine Model of Idiopathic Pulmonary Fibrosis
Published on: June 17, 2025
Primary alveolar proteinosis
Abdul Rab Khan1, Aamir Sulaman, Munir Ahmad Abbasi
1Department of Pulmonology, Ayub Medical College, Abbottabad, Pakistan. abdurrabkhan@hotmail.com
Journal of Ayub Medical College, Abbottabad : JAMC
|July 17, 2013
Summary
A 35-year-old man with worsening dyspnea was initially misdiagnosed and treated for infections. Histopathology confirmed rare pulmonary alveolar proteinosis, highlighting diagnostic challenges for this uncommon lung disease.
Area of Science:
- Pulmonology
- Rare Diseases
- Histopathology
Background:
- Pulmonary alveolar proteinosis (PAP) is a rare lung disorder characterized by surfactant accumulation in alveoli.
- Accurate diagnosis is crucial but can be challenging due to non-specific symptoms.
Observation:
- A 35-year-old male presented with progressive dyspnea and was initially treated with antibiotics and anti-tuberculosis drugs without improvement.
- Despite extensive prior treatment, the patient's condition worsened, indicating a misdiagnosis.
Findings:
- Histopathological examination was essential in definitively diagnosing primary pulmonary alveolar proteinosis.
- The case underscores the importance of considering rare conditions when initial treatments fail.
Implications:
- This case highlights the diagnostic difficulties and the need for prompt histopathological confirmation in suspected pulmonary alveolar proteinosis.
- Reviewing the clinical features, diagnosis, and treatment of this rare disease can improve patient outcomes and guide clinical practice.
Related Concept Videos
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:14Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
01:26Alveoli and Alveolar Ducts
The respiratory zone of the human body, which stands in contrast to the conducting zone, comprises the structures that actively participate in the exchange of gases. The initiation of this zone is marked by the terminal bronchioles converging into respiratory bronchioles, the tiniest bronchiole classification. The respiratory bronchioles give way to the alveolar ducts that opens into a congregation of alveoli. Actively involved in gas exchange, alveoli resemble tiny sacs similar to clusters of...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:10Atelectasis II: Pathophysiology
Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through collapsed...